Back
CNX Resources 10K Form
Buy
69
CNX
CNX Resources
Last Price:
36.54
Seasonality Move:
7.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | CNX/CNX Resources Quarterly |
| 2024-02-08 | 10K | CNX/CNX Resources Annual |
| 2023-10-25 | 10Q | CNX/CNX Resources Quarterly |
| 2023-07-27 | 10Q | CNX/CNX Resources Quarterly |
| 2023-04-27 | 10Q | CNX/CNX Resources Quarterly |
| 2023-02-09 | 10K | CNX/CNX Resources Annual |
Receive CNX News And Ratings
See the #1 stock for the next 7 days that we like better than CNX
CNX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.51B |
|---|---|
| Cash Flow: | $55.42M |
| Price / Cash Flow: | 37.57 |
| Annual Sales: | $28.52 |
| Price / Book: | 1.29 |
Profitability
| EPS (TTM): | 3.18000 |
|---|---|
| Net Income (TTM): | $568.12M |
| Gross Margin: | $529.57M |
| Return on Equity: | 13.44% |
| Return on Assets: | 6.62% |
CNX Resources Earnings Forecast
Key CNX Resources Financial Ratios
- The Gross Profit Margin over the past 27 years for CNX is 35.16%.
- The Selling, General & Administrative Expenses for CNX have been equal to 8.32% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 8.33% of Operating Income.
- The Net Earning history of CNX is 114.23% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 14 years.
CNX Resources Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | CNX |
| CUSIP: | 12653C |
| Website: | cnx.com |
Debt
| Debt-to-Equity Ratio: | 0.54 |
|---|---|
| Current Ratio: | 0.37 |
| Quick Ratio: | 0.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.1 |
|---|---|
| Forward P/E Ratio: | 16.36 |
CNX Technical Analysis vs Fundamental Analysis
Buy
69
CNX Resources (CNX)
is a Buy
Is CNX Resources a Buy or a Sell?
-
CNX Resources stock is rated a Buy
The current CNX Resources [CNX] share price is $36.90. The Score for CNX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.